254 related articles for article (PubMed ID: 33164623)
1. The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy.
Karbasforooshan H; Hayes AW; Mohammadzadeh N; Zirak MR; Karimi G
Cell Cycle; 2020 Dec; 19(23):3209-3221. PubMed ID: 33164623
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of silent information regulator 1 (SIRT1) in hepatocellular carcinoma: a potential therapeutic target.
Wu Y; Meng X; Huang C; Li J
Tumour Biol; 2015 Jun; 36(6):4063-74. PubMed ID: 25926383
[TBL] [Abstract][Full Text] [Related]
4. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target.
Hung CH; Chiu YC; Chen CH; Hu TH
Biomed Res Int; 2014; 2014():486407. PubMed ID: 24800233
[TBL] [Abstract][Full Text] [Related]
6. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
Gailhouste L; Ochiya T
Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and molecular analysis of SIRT7 in hepatocellular carcinoma.
Yanai M; Kurata M; Muto Y; Iha H; Kanao T; Tatsuzawa A; Ishibashi S; Ikeda M; Kitagawa M; Yamamoto K
Pathology; 2020 Aug; 52(5):529-537. PubMed ID: 32586688
[TBL] [Abstract][Full Text] [Related]
8. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.
D'Anzeo M; Faloppi L; Scartozzi M; Giampieri R; Bianconi M; Del Prete M; Silvestris N; Cascinu S
Molecules; 2014 May; 19(5):6393-406. PubMed ID: 24853455
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma.
Bae HJ; Noh JH; Kim JK; Eun JW; Jung KH; Kim MG; Chang YG; Shen Q; Kim SJ; Park WS; Lee JY; Nam SW
Oncogene; 2014 May; 33(20):2557-67. PubMed ID: 23728341
[TBL] [Abstract][Full Text] [Related]
10. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.
Dang S; Zhou J; Wang Z; Wang K; Dai S; He S
Biomed Pharmacother; 2018 Oct; 106():966-975. PubMed ID: 30170358
[TBL] [Abstract][Full Text] [Related]
11. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.
Zhou Y; Liu F; Ma C; Cheng Q
J Clin Lab Anal; 2022 Oct; 36(10):e24673. PubMed ID: 36036748
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs involved with hepatocellular carcinoma (Review).
Mao B; Wang G
Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
[TBL] [Abstract][Full Text] [Related]
13. C/EBPα negatively regulates SIRT7 expression via recruiting HDAC3 to the upstream-promoter of hepatocellular carcinoma cells.
Liu GF; Lu JY; Zhang YJ; Zhang LX; Lu GD; Xie ZJ; Cheng MB; Shen YF; Zhang Y
Biochim Biophys Acta; 2016 Feb; 1859(2):348-54. PubMed ID: 26704017
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics of hepatocellular carcinoma: role of microRNA.
Khare S; Zhang Q; Ibdah JA
World J Gastroenterol; 2013 Sep; 19(33):5439-45. PubMed ID: 24023486
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
[TBL] [Abstract][Full Text] [Related]
16. miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.
Fu Y; Sun LQ; Huang Y; Quan J; Hu X; Tang D; Kang R; Li N; Fan XG
Curr Mol Med; 2018; 18(3):135-141. PubMed ID: 30198432
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5.
Yao B; Li Y; Niu Y; Wang L; Chen T; Guo C; Liu Q
J Cell Mol Med; 2020 Aug; 24(15):8718-8731. PubMed ID: 32596968
[TBL] [Abstract][Full Text] [Related]
18. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled.
Greene CM; Varley RB; Lawless MW
World J Gastroenterol; 2013 Aug; 19(32):5212-26. PubMed ID: 23983424
[TBL] [Abstract][Full Text] [Related]
20. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.
Chen E; Xu X; Liu R; Liu T
Biomed Res Int; 2018; 2018():6784607. PubMed ID: 29951542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]